StockNews.com Begins Coverage on T2 Biosystems (NASDAQ:TTOO)

StockNews.com began coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a note issued to investors on Monday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Price Performance

NASDAQ:TTOO opened at $0.13 on Monday. The company has a 50 day moving average price of $0.22 and a 200-day moving average price of $0.94. T2 Biosystems has a 1-year low of $0.06 and a 1-year high of $6.80.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.